• Enters manufacturing agreement with GLSP Inc. to produce supplements for North American market
• Establishes local US manufacturing presence for enhanced production efficiencies and supply chain logistics
• Ensures products meet highest industry standards, including FDA regulations and ISO-certified quality

EZZ Life Science Holdings Ltd (ASX: EZZ), a genomic life science company, has announced that it has entered into a manufacturing agreement with GLSP Inc. Under this agreement, GLSP Inc. will serve as EZZ's US-based manufacturer, producing a range of nutrition supplements for the North American market. This strategic agreement marks a significant milestone for EZZ as it establishes a local manufacturing presence in the United States, ensuring enhanced production efficiencies, improved supply chain logistics, and strengthened market positioning in North America. Under the terms of the agreement, GLSP Inc. will manufacture EZZ-branded dietary supplements in compliance with the US Food and Drug Administration (FDA) regulations and ISO-certified quality standards. The agreement ensures that all products will be manufactured to the highest industry standards, meeting strict quality control measures, including third-party laboratory testing for microbiological and heavy metal compliance. The partnership aligns with EZZ's broader strategy to expand its global manufacturing and distribution capabilities while catering to the growing demand for high-quality, science-backed health supplements in the US market.

This agreement represents a pivotal step in EZZ's global expansion strategy. By manufacturing in the United States, the company enhances its ability to serve customers in North America with greater speed and efficiency while maintaining its commitment to premium quality and innovation. This partnership strengthens EZZ's supply chain resilience and supports its long-term vision for sustainable growth.